Cytosorbents: COVID-19 Has Presented A Bullish Opportunity [Seeking Alpha]
Cytosorbents Corporation (CTSO)
Last cytosorbents corporation earnings: 11/5 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cytosorbents.com
Company Research
Source: Seeking Alpha
SummaryCytosorbents’ flagship product, CytoSorb can help interrupt the cytokine storm seen in COVID-19 patients with acute respiratory distress syndrome.Cytokine storm or deleterious cytokine cascade is associated with poor prognosis in critically ill COVID-19 patients.I believe COVID-19 pandemic has presented a unique growth opportunity for Cytosorbents.Cytosorbents (CTSOCytosorbents’ CytoSorb blood purification technology has been already used more than 80k times for patients with life-threatening diseases in ICU (intensive care units) and during open-heart surgeries, as the first approved extracorporeal cytokine adsorber in the EU. The technology is already distributed in 58 countries and is used by physicians to control severe inflammation, reverse septic shock, and improve respiratory and other organ functions. Since COVID-19 patients mostly die due to these complications, countries across the world have started using CytoSorb to treat cytokine storm in critically ill COVID-19 pa
Show less
Read more
Impact Snapshot
Event Time:
CTSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTSO alerts
High impacting Cytosorbents Corporation news events
Weekly update
A roundup of the hottest topics
CTSO
News
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Here's Why Shareholders Should Examine Cytosorbents Corporation's (NASDAQ:CTSO) CEO Compensation Package More Closely [Yahoo! Finance]Yahoo! Finance
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00 [Yahoo! Finance]Yahoo! Finance
CTSO
Earnings
- 5/9/24 - In-Line
CTSO
Sec Filings
- 5/22/24 - Form 8-K
- 5/9/24 - Form 8-K
- 5/9/24 - Form 10-Q
- CTSO's page on the SEC website